The University of Nevada, Reno School of Medicine

Checkpoint Choices in Cutaneous Squamous Cell Carcinoma (cSCC): Case-Based Exploration of the Role of PD-1 and New PD-L1 Inhibitors

MD, PhD

Compare programmed cell death protein-1 (PD-1) inhibitors and programmed cell death ligand-1 (PD-L1) inhibitors for cutaneous squamous cell carcinoma (cSCC) based on their mechanism of action  

Select the optimal systemic therapy for the treatment of cSCC in case-based scenarios 

small_image (9).png

thumbnail_image (9).png

image (9).png

Basal Cell Carcinoma

Live Evaluations

WCM26: Checkpoint Choices in Cutaneous Squamous Cell Carcinoma (cSCC): Case-Based Exploration of the Role of PD-1 and New PD-L1 Inhibitors

PD-1 Inhibitors

WCM26: Checkpoint Choices in Cutaneous Squamous Cell Carcinoma (cSCC): Case-Based Exploration of the Role of PD-1 and New PD-L1 Inhibitors

About

Learning Objectives

Intended Audience

Faculty

Accreditation Statement

Credit Designation Statement

Disclosures